Peabody C A, Warner M D, Griffin M, Boutros N N, Worsley I G, Friesen H G
Department of Psychiatry, University of Texas Medical School, Houston.
Psychiatry Res. 1992 Mar;41(3):249-55. doi: 10.1016/0165-1781(92)90006-o.
Fifteen drug-free schizophrenic male inpatients and 14 normal control subjects were studied. The schizophrenic subjects had a significantly lower ratio of bioassay prolactin to radioimmunoassay prolactin before neuroleptic treatment than they did after treatment. The ratio was lower in the drug-free patients as compared with normal controls. These findings suggest that neuroleptic medications may alter the molecular forms of serum prolactin. The results also suggest that drug-free schizophrenic patients may have a different pattern of prolactin variants than normal subjects and that this difference could be secondary to a disordered tuberoinfundibular dopamine system or long-term effects of neuroleptic drugs.
对15名未服用药物的精神分裂症男性住院患者和14名正常对照者进行了研究。精神分裂症患者在接受抗精神病药物治疗前,生物测定催乳素与放射免疫测定催乳素的比值显著低于治疗后。与正常对照组相比,未服用药物的患者该比值较低。这些发现表明,抗精神病药物可能会改变血清催乳素的分子形式。结果还表明,未服用药物的精神分裂症患者可能具有与正常受试者不同的催乳素变体模式,这种差异可能继发于下丘脑漏斗多巴胺系统紊乱或抗精神病药物的长期影响。